Compare Illumina, Inc. (ILMN) vs Symbotic Inc (SYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Symbotic Inc — how do they compare? Illumina, Inc. trades at $275.93 (market cap $39.95B), while Symbotic Inc trades at $42.83 (market cap $5.46B). The key difference: Illumina, Inc. is far larger — about 7.3× Symbotic Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, Symbotic Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Symbotic Inc for 23 Days on average.
| ILMN | SYM | |
|---|---|---|
Market Cap | $39.95B | $5.46B |
Volume | 3,169,503 | 1,965,805 |
Sector | Health | Industrials |
52-Week High | $293.69 | $87.30 |
52-Week Low | $91.00 | $38.22 |
Typical Hold Time | 83 Days | 23 Days |
Enterprise Value | $41.31B | $3.72B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $271.02, up 1.22% and near its 52-week high, reflecting strong momentum. The stock exhibits a bullish technical trend with recent earnings beats and a positive analyst consensus. Revenue for 2025 was $4.34B with net income of $850M, marking a significant profit margin recovery. Cash flow from operations remains robust at $1.08B, supporting financial stability. Inclusion in the S&P 500 and focus on AI-driven genomics growth are key catalysts.
Outlook is positive given earnings momentum and strategic initiatives, but risks include valuation premiums and competitive pressures. The stock offers growth exposure to genomic innovation, though investors should monitor execution on AI integration and margin sustainability. Analyst price targets suggest moderate upside from current levels, with consensus at $241.00.
SYM trades at $42.56, down 1.73% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $16.94 million in 2025, though revenue grew to $2.25 billion. Analysts maintain a consensus Buy rating with a $60.33 price target, citing a robust $22.5 billion backlog and positioning in warehouse automation.
The outlook hinges on execution of its large backlog and diversification beyond key customer Walmart. Near-term risks include recent earnings misses and high valuation multiples relative to current profitability. The stock offers growth potential if margin expansion and recurring revenue targets are met, but faces volatility from execution risks and market sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Symbotic Inc
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →
